Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-095557
Filing Date
2022-04-05
Accepted
2022-04-05 06:08:29
Documents
2
Period of Report
2022-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d347321d6k.htm 6-K 25601
2 GRAPHIC g347321g0405034627553.jpg GRAPHIC 5391
  Complete submission text file 0001193125-22-095557.txt   34317
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 22805122
SIC: 2834 Pharmaceutical Preparations